Barriers to and facilitators of engagement with mHealth technology for remote measurement and management of depression:Qualitative analysis by Simblett, Sara et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.2196/11325
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Simblett, S., Matcham, F., Siddi, S., Bulgari, V., Barattieri, C., Hortas Lopez, J., ... Wykes, T. (2019). Barriers to
and facilitators of engagement with mHealth technology for remote measurement and management of
depression: Qualitative analysis. JMIR mHealth and uHealth, 7(1), [e11325]. https://doi.org/10.2196/11325
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 29. Apr. 2020
Original Paper
Barriers to and Facilitators of Engagement With mHealth
Technology for Remote Measurement and Management of
Depression: Qualitative Analysis
Sara Simblett1, PhD, DClinPsy; Faith Matcham1,2, PhD, CPsychol; Sara Siddi3,4, PhD; Viola Bulgari5, PhD; Chiara
Barattieri di San Pietro5,6, MA; Jorge Hortas López7, MA; José Ferrão8, PhD; Ashley Polhemus8, MSE; Josep Maria
Haro3,4, PhD; Giovanni de Girolamo5, MD; Peter Gamble8, MBA; Hans Eriksson9, MBA, MD, PhD; Matthew Hotopf1,2,
PhD, FRCPsych; Til Wykes1,2, PhD; RADAR-CNS Consortium
1Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom
2National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley National Health Service Foundation
Trust, King's College London, London, United Kingdom
3Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Centro de Investigacion Biomedica en Red CIBERSAM, Madrid, Spain
4Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain
5IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
6Department of Psychology, University of Milano-Bicocca, Milan, Italy
7Research Department, QITERIA Investigación Social Aplicada, Madrid, Spain
8Information Technology Department, MSD Czech Republic, Prague, Czech Republic
9Clinical Development, Depression and Paediatrics, H Lundbeck A/S, Copenhagen, Denmark
Corresponding Author:
Sara Simblett, PhD, DClinPsy
Institute of Psychology, Psychiatry and Neuroscience
King's College London
De Crespigny Park
London, SE5 8AF
United Kingdom
Phone: 44 207 848 0762
Email: sara.simblett@kcl.ac.uk
Abstract
Background: Mobile technology has the potential to provide accurate, impactful data on the symptoms of depression, which
could improve health management or assist in early detection of relapse. However, for this potential to be achieved, it is essential
that patients engage with the technology. Although many barriers to and facilitators of the use of this technology are common
across therapeutic areas and technology types, many may be specific to cultural and health contexts.
Objective: This study aimed to determine the potential barriers to and facilitators of engagement with mobile health (mHealth)
technology for remote measurement and management of depression across three Western European countries.
Methods: Participants (N=25; 4:1 ratio of women to men; age range, 25-73 years) who experienced depression participated in
five focus groups held in three countries (two in the United Kingdom, two in Spain, and one in Italy). The focus groups investigated
the potential barriers to and facilitators of the use of mHealth technology. A systematic thematic analysis was used to extract
themes and subthemes.
Results: Facilitators and barriers were categorized as health-related factors, user-related factors, and technology-related factors.
A total of 58 subthemes of specific barriers and facilitators or moderators emerged. A core group of themes including motivation,
potential impact on mood and anxiety, aspects of inconvenience, and ease of use was noted across all countries.
Conclusions: Similarities in the barriers to and facilitators of the use of mHealth technology have been observed across Spain,
Italy, and the United Kingdom. These themes provide guidance on ways to promote the design of feasible and acceptable
cross-cultural mHealth tools.
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Introduction
Depression is a major cause of disability in Europe and
worldwide. It is associated with a range of negative outcomes
including premature mortality [1], reduced quality of life [2],
loss of occupational function [3], poor social integration and
loneliness [4], and increased risk of other psychiatric problems
such as comorbid anxiety disorders [5] and alcohol dependence
[6]. Experiences of depression are commonly episodic, and the
risk of recurrence following an initial episode is high [7].
With the global increase in availability of mobile phones and
wearable devices [8,9], there is potential for more frequent
health assessment that might help identify signals indicative of
relapse, such as changes in behaviors, circadian rhythms,
stresses, or symptoms [10]. Identification of such indicators
might lead to fast treatment, possibly preventing relapse through
early interventions [10]. However, a critical challenge is user
acceptance of these technologies, particularly, the extent to
which people are willing to engage with the technologies,
considering the level of intrusiveness and possible discomfort.
By engagement, we refer to the extent and manner in which
people actively use resources. The level of engagement should
specifically be important for people who are experiencing
depression, as symptoms such as lack of motivation and interest
to carry out activities (anhedonia) have been shown to influence
the pursuit of potential rewards [11]. Clinical trials of mobile
technologies for individuals with depression have highlighted
engagement as a specific challenge [12].
In order to build on the potential of mobile technologies, we
need to determine the views of people living with or having a
history of depression, so that these views can be embedded at
the start of the mobile health (mHealth) technology-designing
process to ensure maximum applicability, acceptability, and
adoption. This study builds on a recent systematic review of
barriers to and facilitators of engagement with remote
measurement technology [13]. This review used data from
single-country studies, but engagement with mHealth technology
may also be influenced by cultural context [14] in addition to
individual differences. These differences would affect building
of platforms that span across Europe and would need to be taken
into account in the design of mHealth systems to maximize the
value of interventions. This study aimed to identify these
differences through focus groups from three European countries
(Italy, United Kingdom, and Spain), providing an opportunity
to identify a broader range of potential barriers to and facilitators
of engagement and problems with adherence early in order to
support the design of mHealth systems.
Methods
Design
A qualitative approach following a thematic analysis was
employed to identify different experiences and potential barriers
to and facilitators of engagement with mHealth technology
among people with a history of or living with depression. The
topic guide and coding frame were built on a recent systematic
review on barriers to and facilitators of engagement with remote
measurement technology [13]. Within the coding frame, several
pre-established major and minor codes and subthemes emerged
through the use of grounded-theory methods.
Context
Researcher Characteristics
Native speakers in all countries managed the focus groups.
Coordination among the three groups was agreed upon via
telephone and email contact prior to commencing the study,
and a facilitator with training in clinical psychology led each
group. None of the facilitators were directly involved in the
clinical care of the participants. All facilitators were female,
apart from those in Spain, where the facilitators were a man and
a woman. Notably, these characteristics may have influenced
the collection and interpretation of data. To reduce some of this
bias, the coding was replicated by a qualitative researcher who
was not present in the focus group and did not have a
background of clinical psychology. Disagreements in coding
were resolved as a pair, and a joint decision was made about
the allocation of a code to each quotation.
Participant Characteristics
Participants were eligible if they were above the age of 18 years
and were currently experiencing clinically significant symptoms
of major depressive disorder
or had experienced such symptoms in the past 2 years.
Individuals with a history of a psychotic disorder, including
bipolar disorder and schizoaffective disorder, and substance
misuse in the last 6 months were excluded. Participants were
recruited via different sources in the three countries. In the
United Kingdom, potential participants were screened
telephonically by using a self-report measure of depression
(World Health Organization’s Composite International
Diagnostic Interview - Short Form [15]). In Spain and Italy,
clinicians selected patients diagnosed with major depressive
disorder, who attended psychiatric services. Participants were
identified by convenience sampling and their eligibility to
participate. All participants provided written informed consent
to participate in this study.
Procedure
The local research ethics committees for each country approved
the procedures (Ethics codes: United Kingdom, 16/LO/1513;
Italy, Parere 5/2017; Spain, PIC-149-16). All participants were
screened for their eligibility to participate over the phone or in
person. Subsequently, they were invited to participate in a
face-to-face focus group session. In this session, they first
completed a consent form and a demographics questionnaire
before participating in a focus group, as detailed below. All
travel expenses were covered.
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Focus Group
The discussion was semistructured using a prespecified topic
guide (available on request) that was designed to elicit
discussions about barriers to and facilitators of engagement with
mHealth technology in the context of living with a long-term
mental health condition. The open-discussion format allowed
people to share a range of examples. Each group discussion
lasted for 60-120 minutes. This format was developed and tested
in the United Kingdom, where a second focus group with the
same participants was conducted to validate the emerging
findings.
Data Analysis
Focus group discussions were audio recorded and transcribed
verbatim. Both the Italian and Spanish transcripts were translated
into English, allowing combined analyses by two researchers
working independently with the use of the software package
NVivo (version 10; QSR International, Melbourne, Australia).
Subthemes emerging from the data were identified in the final
analysis.
Results
Participant Characteristics
Focus groups were conducted with 25 participants across three
countries (United Kingdom, n=8; Spain, group 1: n=3, group
2: n=5; Italy, n=9). Participants in Spain and Italy were living
with depression for longer than those in the United Kingdom,
and all participants were Caucasian. In Spain, all participants
were female, but the age of the participants was similar across
all three countries (Table 1).
Validation
Textbox 1 displays the subthemes emerging from the data, which
were categorized into prespecified major and minor themes of
the coding frame. Subthemes emerged in all major and minor
codes of the coding frame, except physical ability. This evidence
was taken as validation of the coding frame. Table 2 displays
all the subthemes that emerged for the five different focus
groups separately. Only a small number of additional subthemes
emerged from the Spanish and Italian groups (10/58) after the
focus group in the United Kingdom had taken place.
Table 1. Participant characteristics in each country.
Italy (n=9)Spain (n=8)United Kingdom (n=8)Characteristics
7 (78)8 (100)5 (63)Female, n (%)
52.8 (11.6)47.1 (11.4)51.9 (9.4)Age (years), mean (SD)
11.5 (4.3)13.2 (12.5)2.9 (1.6)Time since diagnosis (years), mean (SD)
Ethnicity, n (%)
9 (100)8 (100)5 (63)White
——
a2 (25)Black
——1 (13)Asian
aNot applicable.
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Textbox 1. Final major and minor codes and subthemes emerging from the discussions
Health-related barriers and facilitators
1. Symptom intensity or severity
• Times of crisis
• Accommodating fluctuations in symptoms
2. Emotional resources
• Lack of motivation
• Doubt
3. Awareness
• Insight
4. Cognition
• Poor memory (forgetfulness)
• Difficulty reading
• Difficulty with spoken expression
5. Physical ability
User-related barriers and facilitators
1. Technology acceptance
• Attitude toward technology
• Nonstigmatizing or familiar
• Digital literacy (self and others)
• Not ready to change
• Codes of practice (eg, dress codes)
2. Perceived utility
• Motivating action
• Raising awareness or understanding
• Sense of control
• Opportunities for connection
• Sense of achievement
• Novelty or enjoyment
• Measuring treatment response
• Thinking more positively
• Improving health and safety
• Sharing data improves care
• Reassuring (others)
• Reassuring (others)
• Contributing to research (others)
3. Perceived costs
• Fears about privacy
• Fears about security
• Negative impact on mood or anxiety
• Time and effort
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Increased dependency•
• Fear of discrimination and stigma
• Unavailable or burden on resources (others)
4. Overall value
• Inaccurate, ineffective, or meaningless
• Balancing utility and costs
• Value of human contact
• Managing expectations
• Inability to sustain resources
• Curiosity
• Trust in experts
Technology-related barriers and facilitators
1. Convenience
• Fitting with routine or lifestyle
• Inconvenience of charging
• Inconvenience of notifications
• Automatic and simplifies life
• Loss of connection
2. Accessibility
• Tailored or personalized
• Expense
• Lacking equipment
3. Convenience
• Ease of use
• Wearable
• Data visualization
• Short assessments
• Poorly designed systems
4. Intrusiveness
• Passive data collection
• Obtrusiveness or discomfort
• Invasion of body
JMIR Mhealth Uhealth 2019 | vol. 7 | iss. 1 | e11325 | p. 5http://mhealth.jmir.org/2019/1/e11325/
(page number not for citation purposes)
Simblett et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 2. Summary of themes across major and minor codes for all countries.
GroupTheme
Italy, (n)Spain (Group 2), (n)Spain (Group 1), (n)UK (Group 1b)b, (n)UK (Group 1a)a, (n)
Health-related theme
——
—
cSymptom inten-
sity or severity
  • Times of crisis (1)• Times of crisis (3)
• Accommodating
fluctuations (1)
Emotional re-
sources
  • Motivation as a
moderator (3)
• Lack of motiva-
tion (1)
• Doubting benefits
(1)
• Lack of motiva-
tion (2)
• Lack of motiva-
tion (2)
——Awareness  ••• Poor insight (3)Poor insight (2)Insight as a moder-
ator (2)
——Cognition  • Forgetfulness (1)• Poor memory (2)• Forgetfulness (1)
• Difficulty reading
(3)
• Difficulty with
spoken expression
(1)
User-related theme
—Technology ac-
ceptance: self
  • Liking technology
as a moderator (3)
• Familiar (1)•• Skepticism to-
wards technology
(4)
Skepticism to-
wards technology
(4)
• Poor digital litera-
cy (1)
• Nonstigmatizing
or familiar (10)
• Nonstigmatizing
or familiar (1)
• Digital literacy as
a moderator (2)
• Not ready to
change (1)
• Dress codes (1)
————Technology ac-
ceptance: others
  • Lack of digital
skills (2)
Perceived utili-
ty: self
  • Reassuring (2)• Sense of control
(2)
• Motivating action
(1)
• Motivating action
(6)
• Motivating action
(4)
• Sharing data im-
proves care (2)
••• Opportunities for
connection (2)
Raising awareness
or understanding
Raising awareness
or understanding
(2)(4) • Improves health
and safety (2)
• Sharing data im-
proves care (1)• Sharing data im-
proves care (1)
• Sense of control
(4) • Improves health
and safety (1)• Novelty or enjoy-
ment (3)
• Opportunities for
connection (3)
• Measure treatment
response (1)
• Sharing data im-
proves care (2)
• Sense of achieve-
ment (1)
• Thinking more
positively (1)
• Novelty or enjoy-
ment (1)
——Perceived utili-
ty: others
  ••• Aiding deci-
sions/communica-
tion (1)
Aiding deci-
sions/communica-
tion (1)
Aiding deci-
sions/communica-
tion (1)
• Contributing to re-
search (8)
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GroupTheme
Italy, (n)Spain (Group 2), (n)Spain (Group 1), (n)UK (Group 1b)b, (n)UK (Group 1a)a, (n)
• Fears about priva-
cy (5)
• Negative impact
on mood/anxiety
(1)
• Time and effort
(2)
• Fear of discrimina-
tion and stigma (7)
• Negative impact
on mood/anxiety
(4)
—• Fears about priva-
cy (4)
• Negative impact
on mood/anxiety
(3)
• Fears about securi-
ty and safety (1)
• Time and effort
(1)
• Fear of discrimina-
tion and stigma (7)
• Fears about priva-
cy (5)
• Negative impact
on mood/anxiety
(5)
• Fears about securi-
ty and safety (3)
• Time and effort
(1)
• Increased depen-
dency (1)
Perceived costs:
self
 
• Unavailable or
burden on re-
sources (1)
——• Unavailable or
burden on re-
sources (1)
• Unavailable or
burden on re-
sources (4)
Perceived costs:
others
 
• Value of human
contact (3)
• Inaccurate, ineffec-
tive, or meaning-
less (1)
• Curiosity (2)
• Trust in experts
(2)
• Inaccurate, ineffec-
tive, or meaning-
less (2)
• Balancing utility
and costs (2)
• Curiosity (2)
• Inaccurate, ineffec-
tive, or meaning-
less (6)
• Balancing utility
and costs (3)
• Managing expecta-
tions (1)
• Sustainability of
resources (2)
• Inaccurate, ineffec-
tive, or meaning-
less (7)
• Balancing utility
and costs (4)
• Value of human
contact (2)
• Managing expecta-
tions (1)
• Inability to sustain
resources (1)
Overall value 
Technology-related theme
• Inconvenient noti-
fications (3)
• Simplifies life (3)
• Loss of connection
(3)
—• Inconvenience of
charging (1)
• Inconvenient noti-
fications (1)
• Automatic and
simplifies life (2)
• Loss of connection
(1)
• Fitting with rou-
tine/lifestyle (9)
• Inconvenience of
charging (1)
• Inconvenient noti-
fications (1)
• Fitting with rou-
tine/lifestyle (2)
Convenience 
• Tailored or person-
alized (2)
• Lacking equip-
ment (1)
—• Expense as a mod-
erator (3)
• Tailored or person-
alized (14)
• Expense as a mod-
erator (2)
• Tailored or person-
alized (9)
Accessibility 
• Ease of use (3)—• Ease of use (1)• Data visualization
(1)
• Ease of use (3)
• Wearable (1)
• Data visualization
(1)
• Short assessments
(1)
• Poorly designed
systems (1)
Usability 
—• Discomfort (2)• Obtrusiveness (1)• Passive data collec-
tion (1)
• Obtrusiveness or
discomfort (3)
• Invasion of body
(1)
• Passive data collec-
tion (4)
• Obtrusiveness (1)
• Live sharing (1)
Intrusiveness 
aThis group discussed prespecified points on the topic guide.
bThis group reviewed topics raised in the first focus group to validate the findings.
cNot applicable.
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Barriers and Facilitators of Engagement
We present our results in 3 main categories: health-related
barriers and facilitators, which included the impact of the health
status of the individual on engagement with technology;
user-related barriers and facilitators, which summarized the
impact of user attitudes, preferences, and beliefs about
engagement with technology; and technology-related barriers
and facilitators, which focus on direct interaction with the
technology.
Participants in the United Kingdom and Italy discussed the
impact of depression on their ability to engage with mHealth
technology. Times of crisis was the most difficult period to
adhere to treatment; one participant mentioned, “at that stage
you just don’t want to do anything. You’re just living in a
self-imposed prison” (UK23). There may be a window of
opportunity for clinical prediction:
Once you get over the edge, there is no going back.
Until the wave passes, and then you get back to
normality, but when we get to that stage, no advice,
no nothing can help us, except ourselves. [UK23]
Adjusting technology to accommodate fluctuations in symptoms
may be important.
Emotional Resources
Lack of motivation was noted in all countries. Some participants
spoke about reduced motivation during depression as “when I
get in a downer, part of the issue is that I just cannot get on with
anything” (UK24). In relation to remote measurement, one
participant said, “I had to fill it in, in the morning, afternoon
and evening. I did it for the first two days, then the third I did
just at morning and afternoon and then stop, I didn’t do it
anymore” (IT6).
Awareness
A subtheme of poor insight into the health status emerged across
the United Kingdom and Spain; a participant stated, “I don’t
always realise that I’ve suffered a dip or a rise” (SP8).
Cognition
The impact of difficulties with cognition that caused problems
with memory, reading, and expression was only mentioned in
Spain. Single participants in the United Kingdom and Italy
mentioned that they might be forgetful, but they did not attribute
this to cognitive difficulties.
Target Users
Participants’ general attitude towards mHealth technology
emerged as a potential moderator of engagement. Participants
in the United Kingdom demonstrated a skeptical attitude:
I don’t think for me personally technology would
work, to be honest, because I’m a person more about
feeling and touching, rather than kind of connecting
with something cold things, and um, electronical
[UK19]
Acceptance may be influenced by digital literacy. One person
was willing to accept technology with extra support, saying
“you’d have to download the application for me because I don’t
really know how those things work” (SP8). Others felt they had
the required skills. Alternatively, some people may not be ready
to change the way they manage their condition. This would be
particularly important for individuals who do not own mobile
technologies.
Acceptance of wearable devices that were nonstigmatizing or
familiar was endorsed. One participant said, “I heard on TV
that almost everyone nowadays has some sort of wearable
device” (SP1); another participant added, “It wouldn’t be
stigmatising. In fact, they’re quite trendy” (UK24). However,
some participants raised concerns about employers not allowing
people to wear devices due to dress codes:
I was just thinking about doctors and nurses and
they’re not allowed to wear anything below their
elbow. [UK22]
UK participants discussed the impact of digital literacy amongst
healthcare professionals, who may also find the use of new
technologies difficult; one participant stated, “I worked with
older GPs and they struggled with the new technology coming
in” (UK18).
Perceived Utility
Target Users
Participants discussed aspects that would provide a utility and
facilitate use. A function was deemed useful if the technology
could motivate action, for example, “go for a walk...do some
meditation” (UK2), or “call your doctor” (UK5):
I sometimes go out for a run and my phone tells me
that it has detected physical activity. Of course, and
when it picks up on that, it also tells me: you still have
time to achieve your goal today [SP1]
One participant in the United Kingdom said that this type of
feedback might help to think more positively; another suggested
that it could lead to a sense of achievement. Some thought that
mHealth technology was novel and enjoyable besides useful.
Raising awareness and understanding of one’s health emerged
as themes from the UK group. One person said “by measuring,
you might discover things that people are not aware of already”
(UK24). Feeling a sense of control and providing opportunities
for connection with others may have further utility, as would
using prompts or alerts to improve health and safety as, for
example, a way to respond to symptoms early:
I have periods when I take medication and periods
when I don’t well...until now, I’ve been the one to
notice that oh, I’m not doing very well, or I’m a bit,
I don’t know. And then after 3 or 4 weeks I’ve touched
rock bottom. Well, maybe if I had some monitoring
before that, then I could take the meds sooner and
not get to that point, so, in my case, maybe it would
be good for me [SP1]
Sharing data with healthcare professionals was considered a
way of improving care by this individual and others in the
Spanish and UK groups. In the Italian group, health monitoring
was considered reassuring.
Participants felt that there was scope for mHealth technology
to support clinical decision making and communication; one
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participant said, “I could see that if um the tracking information
would be useful for my doctor, to help with trying to find the
right medication” (UK22). This view was shared across the
United Kingdom and Spain. In addition, UK participants noted
benefits of contributing to research and the potential wider
impact on others with depression; one participant stated, “I
know there’s a potentially bigger benefit—that’s worthwhile”
(UK20).
Perceived Costs
Target Users
In addition to opportunities for utility, costs were identified.
Participants feared about their privacy and security:
I don’t care if it knows I’ve been to Tesco’s this
morning, don’t give a monkeys. But, I don’t
particularly want people to know I’m in Tesco’s now.
[UK20]
I was given one of those new fashion ones, but I
wanted one that looked cheap, otherwise I’m just
going to get mugged [UK22]
Although these issues were deemed important by some
participants in Italy, one person mentioned, “I really don’t care
about privacy.” [IT9]
Further costs were associated with feeling increased anxiety
about one’s health:
The technology which could remind you, not remind
you, but tell you that you’re going down or something.
That would increase the anxiety, to be honest [UK23]
I wouldn’t recommend it to a hypochondriac. Because
they’d spend all day obsessed, keeping an eye on
what’s happening to them. [SP5]
I’m scared of relapses [SP6]
Concerns about spending time and effort were mentioned by
participants in Italy and the United Kingdom. In addition, there
were concerns about increasing dependency and fear of
discrimination and stigma. Participants suggested that data
gathered might have “implications for travel insurance” (UK24)
or prevent them from being promoted at work; one person stated,
“I wouldn’t want to declare. I wouldn’t want to have a little
badge on me saying I’m depressed.” (UK20).
The main area of concern was the increased burden on resources
for healthcare professionals and its potential negative impact
on care; one participant said, “The more that they’re bombarded
with technology, the less energy there is for normal, human
interaction” (UK18). Healthcare professionals and carers may
not be available to help process information, and signs of
deterioration may not be acted upon even if discovered.
Overall Value
People expressed curiosity about trying new technology. Hope
for the future may provide motivation for engagement:
I’d quite happily do something that was two years,
as long as I thought that if it was successful, there
would be a hope for something afterwards [UK22]
However, others in the UK group questioned the sustainability
of resources, and the importance of balancing utility and costs
was apparent. Investing money and time or making some sort
of sacrifice to benefit from the rewards of the system was
mentioned. One person felt that, overall, the perceived costs
might outweigh the perceived utility. Due to current levels of
information security, they said, “I think it is better not to collect
this kind of personal data in the first place” (UK23). There were
concerns across countries that the data gathered by the
technology might be inaccurate, ineffective, or meaningless.
Nonetheless, participants in Spain expressed trust in researchers
as experts and were willing to be led by their guidance, but
managing participants’ expectations of the achievements
through remote measurement was highlighted as an important
role of researchers in the United Kingdom.
UK and Italian participants emphasized on the value of human
contact. In the Italian group, some participants raised general
concerns about technology limiting the relationship with their
clinician and preferred face-to-face contact rather than telehealth.
Convenience
Participants felt that technology played a role in simplifying
activities and serving a purpose; one participant noted, “if there
is a purpose, if it simplifies my life, I am glad to use it” (IT6).
There were discussions about the pros and cons of wearing
devices that doubled up as watches. The participants believed
that technology should easily fit within a daily routine. Practical
challenges were noted, such as losing opportunities to log data
due to the appearance of notifications at inconvenient timings,
the need for charging, and the loss of connection.
Accessibility
The financial expense associated with the devices was a potential
moderator of accessibility, and practical issues including lack
of equipment were considered a barrier. Even if technology was
available, for it to be accessible, resources need to be tailored
or personalized to meet the specific requirements of individuals.
When a person feels more unwell than usual, this issue may
affect usage. Comments such as “It would depend also on the
severity of symptoms, it must be adjusted” (IT4) and “it must
be tailored to the person’s mood and feelings” (IT8) highlighted
this point.
Usability
mHealth resources should be easy to use and not “fiddly”
(UK24). To reduce the effort needed to engage in surveys, one
participant said, “I’d prefer something that is very short that I
can complete within a minute” (UK20). Simplicity and low
effort appear to be key facilitators, whereas complicated features
or poor design were barriers:
I’ve got a watch my brother gave to me and it
measures your heart rate. But it’s so sophisticated,
you’ve got to stick a cable down here, it’s a bit much
and I say: I’m thinking that I’m not going to wear
this [SP3]
Wearable monitors were endorsed, and the ability to visualize
data was declared important for usability.
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Unobtrusive and comfortable devices were important for
acceptability. Similarly, discreet devices and passive collection
of data were preferred. Only the UK group enquired about how
invasive devices would be implanted under the skin.
A separate issue related to the theme of intrusiveness was the
level of comfort participants felt with live sharing of data with
others:
If its location, I’d rather it didn’t know, that data
wasn’t live imported, instead when I’m not where the
watch is telling, because you can get into live imports
and just, everyone knows where you are all the time.
And some of my cousins are quite happy to know
where each other are 24/7, I find that scary…
horrible, I don’t want that. [UK20]
Knowing who the data would be shared with was deemed
important, and some participants suggested that sharing data
with clinicians may be more acceptable than sharing them with
profit-driven organizations.
Cross-Country Comparisons
Almost half the themes were similar across at least two
countries, suggesting replication and an acceptable level of data
saturation [16]. A core group of themes was repeated across all
countries: the need for motivation, the potential negative impact
on anxiety and mood, the inconvenience of too-frequent
notifications, and the importance of ease of use. A number of
key differences regarding additional subthemes emerged
between regions. First, although the UK group provided an
extensive list of utility examples, they were skeptical about the
use of mHealth technology. Similarly, the Spanish participants
had many issues with perceived utility. In contrast, the Italian
group focused more on perceived costs. Participants in Spain
were the only group to trust the experts. The UK group was
uncertain about the digital skills and availability of resources
in clinical practice. Acceptance of technology from the
perspective of other people in their health systems, such as
clinicians, was not raised as a concern in Spain or Italy. One
older participant textboxin Italy expressed the inability to access
equipment. Second, issues regarding usability were discussed
in greater depth in the UK group. Although the ease of use was
the only subtheme in the Italian and Spanish groups, some
specific suggestions about data visualization, length of
assessments, and the ease of wearables emerged in the UK
group. Few technology-related barriers and facilitators emerged
in Spain, where participants focused more on health-related and
user-related themes than technology-related themes.
Discussion
Principal Findings
In this study, 3 major, 14 minor, and 58 subthemes emerged
from the data; some were related to functionality of technology
and others were about users’ abilities, perceptions, and attitudes
toward technology. These nonfunctional requirements have
been reported previously [17]. Our nonfunctional requirements
were categorized as health-related and user-related barriers and
facilitators (Figure 1).
Figure 1. Requirements for engagement with mobile health (mHealth) technology for depression.
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Nonfunctional Requirements
In terms of health-related barriers and facilitators, the severity
of symptoms may moderate engagement with mHealth
technology. Low motivation and intermittent poor insight and
memory are known to be symptoms of depression and may be
specific to this population [18], which may affect mHealth
systems that require direct interaction with an app as well as
users’ decisions to wear devices. However, the absence of data
could be as informative as its presence in algorithms created to
identify the risk of relapse.
In terms of user-related barriers and facilitators, participants’
attitudes toward mHealth technology affected their engagement.
Similarly, digital literacy moderates the use of technology [19],
and as the results of this study suggest, affects all users including
the healthcare providers who support patients. Familiarity with
technology and employment regulations may either further
facilitate technology adoption or pose a barrier for use.
Our participants emphasized the importance of weighing costs
against utility in order to make a decision about the overall value
of mHealth technology. Utility included factors such as
opportunities to connect with others; prompts; raising awareness
and understanding; a sense of control; and responding to early
warning signs by, for example, supporting clinical decision
making. Perceived costs included reduced privacy and security;
lack of availability and limited resources to support use;
increased health anxiety or dependency; and expending time
and effort, especially if there were inaccuracies in measurement.
Functional Requirements
Previous research demonstrated a relationship between perceived
convenience and usability, and the acceptance of technology
[20]. Similarly, mHealth technologies were thought to be easier
to accept if they reduced effort, served a clear purpose, fit into
one’s daily routine, were comfortable, and promoted choice or
control. Barriers included the receipt of notifications at
inconvenient times and the need to charge devices or fix
technical malfunctions. In addition to convenience and usability,
previous literature has advocated the development of resources
that are accessible or equally available to all users (eg, “universal
design”) [21], and this work has reiterated the need for such
development with respect to depression-specific symptoms.
Geographical Requirements
The subthemes that emerged from multiple countries
demonstrate some of the most important considerations for
developing mHealth resources across Europe. Motivation is a
key moderator of engagement. Two barriers across countries
were the potential negative effect on anxiety and mood and the
inconvenience of too-frequent notifications, which may be
related. Focus on an easy-to-use design was clear. Some
differences between the countries may relate to diversity in
health care experience and the availability of or familiarity with
mHealth technology. There is variation in the percentage of
adults using mobile phones and internet-based technologies
across Europe; Italy has lower access to these technologies than
Spain and the United Kingdom [22]. Varied familiarity with
mHealth technology may account for fewer examples of utility
and greater concerns about potential costs in Italy, where some
people may not be fully aware of the benefits and may have
raised potential concerns about the loss of human interaction.
Results from this study are similar to those of a systematic
review on barriers to and facilitators of engagement with remote
measurement technology [13]. However, our study focused on
the attitudes of individuals with depression toward technology
and the nonfunctional, rather than functional, factors. Motivation
was clearly an important category, but was incorporated into
health-related barriers and facilitators in this study, due to the
inextricable link between mood and emotional resources for
people with depression; their physical abilities were never
discussed. Although a few previous studies reported the
acceptability and feasibility of mHealth resources for people
with mental health conditions (eg, [23-26]), none of them
explored barriers and facilitators across several countries.
This study uniquely provides views from participants living in
different countries and revealed both similar and potentially
different issues that were considered by the different groups.
Although mHealth resources should take into account the
similarities of views, it is essential to continue monitoring
engagement across different countries, as these differences may
affect their efficient implementation.
Strengths and Limitations
Strengths of this study were the inclusion of a varied sample
that represented three European countries that place similar
emphasis on community-based or “remote” treatment
interventions for mental health. The qualitative approach enabled
a rich, in-depth discussion of possible barriers to and facilitators
of engagement with mHealth technology. It was not constrained
to responses to specific questions, which allowed the discovery
of themes that may not have emerged otherwise.
Although another strength of the study was the cross-national
approach to understand factors influencing engagement, it is
important to note that the translation may have influenced the
findings. A further key limitation is the dependence of our
results on hypothetical scenarios rather than actual experience.
We have identified several themes that can guide research design
and technological development, but we should be cautious about
the anticipated risks or benefits that may not be sustained when
people are exposed to technology. Further user testing with
specific prototypes is required to maximize acceptability and
usability. Such user testing will include a wider sample of the
population with a history or current symptoms of depression,
which will involve purposive sampling.
Future Research
Future research should consider other stakeholders. Craven et
al [17] advocate the involvement of all possible end users
including carers and clinicians, which may result in systems
that are easily implemented in practice. A few studies that
implemented this holistic perspective and involved several users
[27] found commonalities in terms of universal support for
technology innovation and potential barriers to the use of
mHealth technology, similar to those identified in this study.
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Conclusion
This qualitative study investigated the potential barriers to and
facilitators of engagement with mHealth technology. A number
of functional and nonfunctional categories emerged with both
similarities and differences across European countries. The
themes form a platform for future research on engagement with
mHealth technology as a part of healthcare. A number of
hypotheses have been generated: Increased familiarity and
perceived utility, improved choice and control, greater
convenience and accessibility, and lower intrusiveness may
influence decisions about the use and engagement of mHealth
technology and should be encouraged and evaluated in future
studies, as the data might provide useful to improve existing
models.
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